Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Drug Resistance

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 43 articles:
HTML format
Text format



Single Articles


    May 2017
  1. POPOVICH KJ, Snitkin ES, Hota B, Green SJ, et al
    Genomic and Epidemiological Evidence for Community Origins of Hospital-Onset Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    J Infect Dis. 2017 May 9. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  2. KAKIUCHI S, Tsuji M, Nishimura H, Yoshikawa T, et al
    Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus Type 1 With Prognosis in Hematopoietic Stem Cell Transplantation Patients.
    J Infect Dis. 2017;215:865-873.
    PubMed     Text format     Abstract available


  3. MAVE V, Chandanwale A, Kagal A, Khadse S, et al
    High Burden of Antimicrobial Resistance and Mortality Among Adults and Children with Community-Onset Bacterial Infections in India.
    J Infect Dis. 2017 Mar 3. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. OECHSLIN F, Piccardi P, Mancini S, Gabard J, et al
    Synergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence.
    J Infect Dis. 2017;215:703-712.
    PubMed     Text format     Abstract available


    February 2017
  5. RAY SM
    Preventing Methicillin-Resistant Staphylococcus aureus (MRSA) Disease in Urban US Hospitals-Now for the Hard Part: More Evidence Pointing to the Community as the Source of MRSA Acquisition.
    J Infect Dis. 2017 Feb 22. doi: 10.1093.
    PubMed     Text format    


  6. GEISINGER E, Isberg RR
    Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  7. GOMEZ-SIMMONDS A, Uhlemann AC
    Clinical Implications of Genomic Adaptation and Evolution of Carbapenem-Resistant Klebsiella pneumoniae.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  8. LOGAN LK, Weinstein RA
    The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  9. MURRAY GL, Tsyganov K, Kostoulias XP, Bulach DM, et al
    Global Gene Expression Profile of Acinetobacter baumannii During Bacteremia.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  10. PARKER D
    Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  11. HENRY CS, Rotman E, Lathem WW, Tyo KE, et al
    Generation and Validation of the iKp1289 Metabolic Model for Klebsiella pneumoniae KPPR1.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  12. AHN D, Prince A
    Host-Pathogen Interface: Progress in Understanding the Pathogenesis of Infection Due to Multidrug-Resistant Bacteria in the Intensive Care Unit.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  13. JUAN C, Pena C, Oliver A
    Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  14. KAKIUCHI S, Tsuji M, Nishimura H, Yoshikawa T, et al
    The Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus 1 with the Prognosis in Hematopoietic Stem Cell Transplantation Patients.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    


    January 2017
  15. WATERS EM, Rudkin JK, Coughlan S, Clair GC, et al
    Redeploying beta-Lactam Antibiotics as a Novel Antivirulence Strategy for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections.
    J Infect Dis. 2017;215:80-87.
    PubMed     Text format     Abstract available


    December 2016
  16. STEEGEN K, Bronze M, Papathanasopoulos MA, van Zyl G, et al
    Prevalence of Antiretroviral Drug Resistance in Patients Who Are Not Responding to Protease Inhibitor-Based Treatment: Results From the First National Survey in South Africa.
    J Infect Dis. 2016;214:1826-1830.
    PubMed     Text format     Abstract available


    November 2016
  17. PLANET PJ, Diaz L, Rios R, Arias CA, et al
    Global Spread of the Community-Associated Methicillin-Resistant Staphylococcus aureus USA300 Latin American Variant.
    J Infect Dis. 2016;214:1609-1610.
    PubMed     Text format    


    September 2016
  18. KAN H, Imamura M, Uchida T, Hiraga N, et al
    Protease inhibitor resistance remains even after mutant strains become undetectable using deep sequencing.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  19. YU KO, Randolph AG, Agan AA, Yip WK, et al
    Staphylococcus aureus alpha-toxin Response Distinguishes Respiratory Virus-MRSA Co-infection in Children.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  20. ANGELO KM, Reynolds J, Karp BE, Hoekstra RM, et al
    Antimicrobial Resistance among Nontyphoidal Salmonella Isolated from Blood in the United States, 2003-2013.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    August 2016
  21. LI L, Cheung A, Bayer AS, Chen L, et al
    The Global Regulon sarA Regulates beta-lactam Antibiotic Resistance In Methicillin-resistant Staphylococcus aureus (MRSA) In Vitro and In Endovascular Infections.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    July 2016
  22. DOSTER RS, Kirk L, Tetz LM, Rogers LM, et al
    Staphylococcus aureus infection of human gestational membranes induces bacterial biofilm formation and host production of cytokines.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  23. BOENDER TS, Hamers RL, Ondoa P, Wellington M, et al
    Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    June 2016
  24. AZARIAN T, Daum RS, Petty LA, Steinbeck JL, et al
    Intra-host evolution of methicillin-resistant Staphylococcus aureus USA300 among individuals with reoccurring skin and soft tissue infections.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    April 2016
  25. TOLEMAN MS, Reuter S, Coll F, Harrison EM, et al
    Systematic surveillance detects multiple silent introductions and household transmission of methicillin-resistant Staphylococcus aureus USA300 in the east of England.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    March 2016
  26. RUSSO TA, Spellberg B, Johnson JR
    Important Complexities of the Antivirulence Target Paradigm: A Novel Ostensibly Resistance-Avoiding Approach for Treating Infections.
    J Infect Dis. 2016;213:901-3.
    PubMed     Text format     Abstract available


  27. GELFAND MS, Cleveland KO
    Reversion From Methicillin Susceptibility to Methicillin Resistance in Staphylococcus aureus.
    J Infect Dis. 2016.
    PubMed     Text format    


  28. LANIER ER, Foster S, Brundage T, Chou S, et al
    Analysis of Cytomegalovirus DNA Polymerase Gene Mutations in a Phase 2 Clinical Trial of Brincidofovir Prophylaxis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    January 2016
  29. KOBAYASHI SD, Porter AR, Dorward DW, Brinkworth AJ, et al
    Phagocytosis and killing of carbapenem-resistant ST258 Klebsiella pneumoniae by human neutrophils.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    December 2015
  30. ARSHAD M, Goller CC, Pilla D, Schoenen FJ, et al
    Threading the needle: small molecule targeting of a xenobiotic receptor to ablate Escherichia coli polysaccharide capsule expression without altering antibiotic resistance.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  31. L'HUILLIER AG, Abed Y, Petty TJ, Cordey S, et al
    E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient.
    J Infect Dis. 2015;212:1726-34.
    PubMed     Text format     Abstract available


    November 2015
  32. SVAROVSKAIA ES, Gane E, Dvory-Sobol H, Martin R, et al
    L159F and V321A Sofosbuvir Resistance Associated HCV NS5B Substitutions.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  33. PENROSE K, Parikh UM, Hamanishi KA, Else L, et al
    Selection of Rilpivirine Resistant HIV-1 in a Seroconverter on Long-Acting Rilpivirine (TMC278LA) from the Lowest Dose Arm of the SSAT040 Trial.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    September 2015
  34. POOLMAN JT, Wacker M
    Extra-intestinal Pathogenic Escherichia coli (ExPEC), a common human pathogen: challenges for vaccine development and progress in the field.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    July 2015
  35. LEIMER N, Rachmuhl C, Palheiros Marques M, Bahlmann AS, et al
    Non-stable Staphylococcus aureus small colony variants are induced by low pH and sensitized to antimicrobial therapy by phagolysosomal alkalinization.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  36. DERACHE A, Wallis CL, Vardhanabhuti S, Bartlett J, et al
    Phenotype, Genotype and Drug Resistance in Subtype C HIV-1 Infection.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  37. ZHOU N, Hernandez D, Ueland J, Yang X, et al
    NS5A Sequence Heterogeneity and Mechanisms of Daclatasvir Resistance in Hepatitis C Virus Genotype 4 Infection.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  38. VAN DER VRIES E, Ip DK, Cowling BJ, Zhang JD, et al
    Outcomes and Susceptibility to Neuraminidase Inhibitors in Individuals Infected with Different Influenza B Lineages: the Influenza Resistance Information Study.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  39. KWIECINSKI J, Peetermans M, Liesenborghs L, Na M, et al
    Staphylokinase controls Staphylococcus aureus biofilm formation and detachment through host plasminogen activation.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  40. HERMANS LE, Svicher V, Pas SD, Salpini R, et al
    Combined Analysis of the Prevalence of drug Resistant HBV in antiviral therapy Experienced patients in Europe (CAPRE).
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    June 2015
  41. LISCHKA P, Michel D, Zimmermann H
    Characterization of cytomegalovirus breakthrough events in a letermovir (AIC246, MK 8228) phase 2 prophylaxis trial.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  42. SALVATORE PP, Becerra MC, Zur Wiesch PA, Hinkley T, et al
    Fitness Costs of Drug-resistance Mutations in Multidrug Resistant M. tuberculosis: A Household-based Case-control Study.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    May 2015
  43. TAMURA D, DeBiasi RL, Okomo-Adhiambo M, Mishin VP, et al
    Emergence of multidrug resistant influenza A(H1N1)pdm09 virus variants in an immunocompromised child treated with oseltamivir and zanamivir.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: